Position in INCY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$7,611,860
-$186,821 QoQ
Shares Held
80,874
+2.4% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.7678611172935678.ToString("F0")%
Shared 0.ToString("F0")%
None 99.23213888270644.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Sep 30, 2020CallValue
$17,948
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Creative Planning holds $360,280,712 across 212 Biotechnology names. INCY ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
109,524 | $48,906,846 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,152 | $31,023,040 | |
| 3 | INSM |
INSMED Inc
|
72,200 | $11,806,143 | |
| 4 | EXEL |
Exelixis, Inc.
|
234,142 | $10,042,350 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
119,661 | $8,886,025 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
140,177 | $8,145,685 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,122 | $7,981,245 | |
| 8 | INCY |
Incyte Corp
This page
|
80,874 | $7,611,860 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,611,860 | 80,874 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,798,681 | 78,958 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,029,147 | 59,299 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,254,517 | 33,106 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,679,778 | 27,742 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,891,550 | 27,386 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,478,392 | 22,366 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $1,276,592 | 21,059 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $1,057,533 | 18,563 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $949,509 | 15,122 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $605,313 | 10,478 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $603,949 | 9,702 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $560,381 | 7,754 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $632,841 | 7,879 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $573,770 | 8,610 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $755,977 | 9,951 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $529,016 | 6,661 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $630,652 | 8,592 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $505,326 | 7,347 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $614,990 | 7,310 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $575,716 | 7,084 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $653,393 | 7,512 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $17,948 | 200 | Call | Sole | 2020-11-05 | |
| 2020-09-30 | $638,230 | 7,112 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $703,980 | 6,771 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $510,413 | 6,970 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||